Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.Lam JR, Schneider JL, Quesenberry CP, Corley DA. Gastroenterology. 2016 Nov 24. [Epub ahead of print]
BACKGROUND AND AIMS:Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) suppress gastric acid production, which may inhibit iron absorption. However, little data exist regarding whether these medications increase the risk of clinical iron deficiency.METHODS:A community-based case-control study evaluated the association between acid-suppressing medication use and the subsequent risk of iron deficiency.
It contrasted 77,046 patients with new iron deficiency diagnoses (January, 1999-December, 2013), with 389,314 controls. Medication exposures, outcomes, and potential confounders used electronic databases. We excluded patients with pre-existing risk factors for iron deficiency. Associations were estimated using conditional logistic regression.RESULTS:Among cases, 2,343 (3·0%) received a prior ≥2-year supply of PPIs and 1,063 (1·4%) received H2RAs (without PPI use). Among controls, 3,354 (0·9%) received a prior ≥2-year supply of PPIs and 2,247 (0·6%) H2RAs. Both ≥2 years of PPIs (adjusted odds ratio [OR]: 2·49; 95% confidence interval [CI]: 2·35-2·64) and ≥2 years of H2RAs (OR: 1·58, 95% CI: 1·46-1·71) were associated with an increased subsequent risk for iron deficiency. Among PPI users, the associations were stronger for higher daily doses (>1·5 vs. <0·75 PPI pills/day; p-value interaction =0·004) and decreased after medication discontinuation (P-trend < 0·001). Some of the strongest associations were among persons taking >1.5 pills per day for at least 10 years (OR: 4·27, 95% CI: 2·53-7·21). No similar strong associations were found for other commonly used prescription medications.CONCLUSIONS:Among patients without known risk factors for iron deficiency, gastric acid inhibitor use for ≥2 years was associated with an increased subsequent risk of iron deficiency. The risk increased with increasing potency of acid inhibition and decreased after medication discontinuation.


